EcoDrugPlus

Ensembl ID : ENSCSAVG00000001408
Gene Symbol: -
1 Cross references
417 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001464
Gene Symbol: -
1 Cross references
201 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001465
Gene Symbol: -
1 Cross references
201 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001663
Gene Symbol: -
1 Cross references
256 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001796
Gene Symbol: -
1 Cross references
453 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002002
Gene Symbol: -
1 Cross references
242 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002069
Gene Symbol: -
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002132
Gene Symbol: -
1 Cross references
208 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002312
Gene Symbol: -
1 Cross references
221 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002426
Gene Symbol: -
1 Cross references
294 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002550
Gene Symbol: -
1 Cross references
559 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002557
Gene Symbol: -
1 Cross references
1156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).